Com. v. Perralta, E.

Superior Court of Pennsylvania·Decided October 21, 2024·No. 690 MDA 2023·Unpublished

Opinion

NON-PRECEDENTIAL DECISION - SEE SUPERIOR COURT O.P. 65.37

COMMONWEALTH OF PENNSYLVANIA : IN THE SUPERIOR COURT OF : PENNSYLVANIA

:

v. :

:

:

EMELIO PERRALTA :

:

Appellant : No. 690 MDA 2023

Appeal from the PCRA Order Entered April 19, 2023 In the Court of Common Pleas of Lancaster County Criminal Division at No(s): CP-36-CR-0001867-2020, CP-36-CR-0005261-2020, CP-36-CR-0006636-2019, CP-36-CR-0006637-2019

BEFORE: DUBOW, J., BECK, J., and COLINS, J.* MEMORANDUM BY COLINS, J.: FILED: OCTOBER 21, 2024 Appellant, Emelio Perralta, appeals from the order of the Court of Common Pleas of Lancaster County that denied his petition filed under the Post Conviction Relief Act (PCRA).1 Counsel for Appellant in this appeal (PCRA appellate counsel) has filed an application to withdraw and a brief asserting that the appeal of the denial of Appellant’s PCRA claim has no arguable merit. After careful review, we affirm the PCRA court’s ruling rejecting the ground for relief litigated below by Appellant’s prior counsel (PCRA counsel) but vacate in part its denial of the PCRA petition and remand for the PCRA court to

* Retired Senior Judge assigned to the Superior Court.

1 42 Pa.C.S. §§ 9541-9546.

address five claims of PCRA counsel ineffectiveness that Appellant has raised in this appeal. Because PCRA appellate counsel has not shown that the appeal is wholly without merit, we deny the application to withdraw.

This appeal arises from Appellant’s sale of fentanyl that caused the November 8, 2019 death of a woman who used it (Victim), fentanyl buys from Appellant on August 7 and September 26, 2019, and fentanyl found on Appellant’s person when he was arrested on November 23, 2019. Appellant was charged at separate dockets with delivery of fentanyl for the August 7, 2019 buy, delivery of fentanyl for the September 26, 2019 buy, drug delivery resulting in death for the fentanyl sale that caused Victim’s death, and possession with intent to deliver (PWID) for the fentanyl found on his person when he was arrested.

On February 26, 2021, the Commonwealth filed a motion to join the four cases for trial. Appellant's trial counsel did not oppose the motion, and the trial court on July 20, 2021, ordered the cases consolidated for trial. A jury trial commenced on December 6, 2021. At trial, the Commonwealth’s evidence with respect to the drug delivery resulting in death charge showed that Victim died from a fentanyl overdose in the morning hours of November 8, 2019, that Appellant sold fentanyl to Tyler Blantz the day before, that Blantz shared that fentanyl with Victim, who was his girlfriend, and that Victim injected that fentanyl the evening before her death. N.T. Trial at 231, 235- 38, 287, 289, 291-306, 325-26, 334-45, 357, 365-73, 386, 395-98. Appellant

testified in his own defense at trial and testified that the only time that he supplied drugs to Blantz was a week or two after Victim’s death. Id. at 509. Appellant also testified that he never supplied any drugs to Victim because he was told not to give drugs to Victim no matter how sick she claimed to be since she had just come out of rehab. Id. at 509-10.

The trial court instructed the jury on drug delivery resulting in death as follows:

To find the defendant guilty of [drug delivery resulting in death], you must find that the following elements have been proven beyond a reasonable doubt: First, that the defendant administered, dispensed, delivered, gave, prescribed, sold or distributed a controlled substance or a counterfeit controlled substance to a person. Second, that the defendant did so intentionally, that is, it was his conscious object to administer, dispense, deliver, give, prescribe, sell or distribut[e] a controlled substance or counterfeit controlled substance to a person. Third, that the administration, dispense, delivery, prescription or sale was in violation of the Controlled Substance, Drug, Device and Cosmetic Act. And, fourth, that a person has died as a result of using that substance. Proof of malice is not an element of that crime. If you find that each of these elements have been proven beyond a reasonable doubt, then you should find the defendant guilty. If you do not find each proven beyond a reasonable doubt, then you must find him not guilty.

N.T. Trial at 586-87. Appellant’s trial counsel did not object to that instruction or request any additional instruction on the drug delivery resulting in death charge. Id. at 590. On December 9, 2021, the jury convicted Appellant of all of the charges. Id. at 596-99. On March 9, 2022, the trial court sentenced Appellant to an aggregate term of imprisonment of 9 to 18 years’ incarceration, consisting of consecutive sentences of 6 to 12 years for the drug

delivery resulting in death conviction and 3 to 6 years for PWID and concurrent sentences of 2 to 5 years on the other charges. Sentencing Orders. Appellant filed timely direct appeals but discontinued the appeals on April 21, 2022.

On April 29, 2022, Appellant filed a timely pro se PCRA petition asserting multiple claims of ineffective assistance of trial counsel, including claims that his trial counsel was ineffective for failing to object to the trial court’s jury instruction on the drug delivery resulting in death charge and for failing to challenge the consolidation of the cases, and the PCRA court appointed PCRA counsel for Appellant. On July 20, 2022, PCRA counsel filed an amended PCRA petition that asserted two claims for relief: (1) that trial counsel was ineffective for failing to object to the trial court’s omission in its drug delivery resulting in death instruction of the mens rea of recklessness that the Commonwealth must prove with respect to causation of the death and (2) that trial counsel was ineffective for failing to move to sever the cases.

On January 3, 2023, the PCRA court held a hearing on the amended PCRA petition at which Appellant’s trial counsel and Appellant testified. At the start of the hearing, PCRA counsel advised the court that he was withdrawing the claim trial counsel was ineffective for failing to seek severance and that only Appellant’s claim of ineffectiveness of trial counsel with respect to the jury instruction on drug delivery resulting in death would be addressed at the hearing. N.T. PCRA at 3. Appellant’s trial counsel testified that she believed that the trial court’s drug delivery resulting in death instruction was an

accurate statement of the law because it was the standard jury instruction and that she did not believe that there was any basis to object to the instruction. Id. at 9, 15-16. Trial counsel testified that at the time of the PCRA hearing she believed that the crime of drug delivery resulting in death required that the Commonwealth prove that the defendant acted recklessly with regard to causing the death but could not recall whether she knew that at the time of Appellant’s trial. Id. at 12. Appellant did not testify to any conversations with trial counsel or concerning the jury instruction but admitted that he testified at trial that he knew not to give Victim drugs because she had just gotten out of rehab. Id. at 23-24.

On April 19, 2023, the PCRA court denied Appellant’s PCRA petition.

PCRA Court Order, 4/19/23. Appellant filed a timely pro se appeal and, in response to the PCRA court’s Pa.R.A.P. 1925(b) order, filed both a timely pro se statement of errors complained of on appeal and a subsequent pro se amended statement of errors. The pro se amended statement of errors asserted that the PCRA court erred in denying Appellant’s claim of trial counsel ineffectiveness with respect to the drug delivery resulting in death jury instruction and also set forth the following seven claims of PCRA counsel ineffectiveness:

1) PCRA Counsel was ineffective for failing to raise trial counsel’s ineffectiveness for failing to present appellant’s alibi witness.

Free access — add to your briefcase to read the full text and ask questions with AI

Com. v. Perralta, E., (Pa. Ct. App. 2024).

Com. v. Perralta, E. (Com. v. Perralta, E.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Anders v. California
386 U.S. 738 (Supreme Court, 1967)
Commonwealth v. Ketterer
725 A.2d 801 (Superior Court of Pennsylvania, 1999)
Commonwealth v. McGill
832 A.2d 1014 (Supreme Court of Pennsylvania, 2003)
Commonwealth v. Turner
544 A.2d 927 (Supreme Court of Pennsylvania, 1988)
Commonwealth v. Widgins
29 A.3d 816 (Superior Court of Pennsylvania, 2011)
Commonwealth v. Humpheys
532 A.2d 836 (Supreme Court of Pennsylvania, 1987)
Commonwealth v. Moran, Aplt
104 A.3d 1136 (Supreme Court of Pennsylvania, 2014)
Commonwealth v. Freeland
106 A.3d 768 (Superior Court of Pennsylvania, 2014)
Commonwealth v. Eichinger, J., Aplt
108 A.3d 821 (Supreme Court of Pennsylvania, 2014)
Commonwealth v. Kakhankham
132 A.3d 986 (Superior Court of Pennsylvania, 2015)
Commonwealth v. Mason, L., Aplt
130 A.3d 601 (Supreme Court of Pennsylvania, 2015)
Commonwealth v. Walters
135 A.3d 589 (Superior Court of Pennsylvania, 2016)
Commonwealth v. Storey
167 A.3d 750 (Superior Court of Pennsylvania, 2017)
Commonwealth, Aplt. v. Montalvo, M.
205 A.3d 274 (Supreme Court of Pennsylvania, 2019)
Commonwealth v. Nichols
692 A.2d 181 (Superior Court of Pennsylvania, 1997)
Commonwealth v. Doty
48 A.3d 451 (Superior Court of Pennsylvania, 2012)
Commonwealth v. Stewart
84 A.3d 701 (Superior Court of Pennsylvania, 2013)
Commonwealth v. Safrit
538 A.2d 1335 (Supreme Court of Pennsylvania, 1988)
Commonwealth v. Jones
210 A.3d 1014 (Supreme Court of Pennsylvania, 2019)
Com. v. Scott, J.
2024 Pa. Super. 232 (Superior Court of Pennsylvania, 2024)